Cleared Traditional

K950878 - MENICON SP VIAL

K950878 is an FDA 510(k) clearance for MENICON SP VIAL, manufactured by Hyman, Phelps & McNamara, P.C.. The device is a Class 2 Ophthalmic device with product code LRX cleared through the Traditional 510(k) pathway after a 38-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1995
Decision
38d
Days
Class 2
Risk

K950878 is an FDA 510(k) clearance for the MENICON SP VIAL. Classified as Case, Contact Lens (product code LRX), Class II - Special Controls.

Submitted by Hyman, Phelps & McNamara, P.C. (Washington Dc, US). The FDA issued a Cleared decision on April 7, 1995 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5928 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K950878

510(k) Number K950878 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 1995
Decision Date April 07, 1995
Days to Decision 38 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 110d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LRX Device Classification - Class 2, Special Controls

Product Code LRX Case, Contact Lens
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.5928
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - LRX Case, Contact Lens

All 81
Devices cleared under the same product code (LRX) and FDA review panel - the closest regulatory comparables to K950878.
RYDER CONTACT LENS CASE MODEL 10670
K951182 · Bradstreet Clinical Research Assoc., Inc. · May 1995
RYDER CONTACT LENS CASE
K951181 · Bradstreet Clinical Research Assoc., Inc. · May 1995
PRO-TEC-CASE
K950530 · Hyman, Phelps & McNamara, P.C. · Apr 1995
DATEMINDER CONTACT LENS CASE
K945259 · Bruce A. Berkley · Jan 1995
RYDER CONTACT LENS CASE
K943921 · Clinical Research Assoc. · Oct 1994
CIBA VISION(R) CONTACT LENS CASE
K943183 · Ciba Vision Corporation · Aug 1994